BridgeMD
New treatment option for Gestational Diabetes Mellitus in Pregnancy
Official title Impact of Behavioural Modification Working Toolkit Among Women With Gestational Diabetes Mellitus and Hypertension
ClinicalTrials.gov ID: NCT07551011
What this study is testing
- What it's testing
- This trial aims to evaluate the effectiveness of a Behavioral Modification Working (BMW) Toolkit in improving glycemic control and blood pressure among pregnant women diagnosed with both GDM and PIH.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 49, women only
You may be able to join if
- Pregnant women aged 15-49 years.
- Gestational age between 16 and 20 weeks at enrolment.
- Diagnosed with both gestational diabetes mellitus (GDM) and pregnancy-induced hypertension (PIH).
- At least one prior antenatal visit at the study site.
You likely can't join if
- Pre-existing diabetes mellitus or chronic hypertension prior to pregnancy.
- Pre-existing renal disease, thyroid disease, or major hematological disorders.
- Multiple pregnancy (e.g., twins, triplets).
- Severe psychiatric illness.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 15 years to 49 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.